KAYLA KAWA: Open Payments
NPI 1851085062 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 18 payments from 11 companies in 2025. Trend: 2023 $100 · 2024 $223 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $87 |
| Exact Sciences Corporation | 3 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Phadia US Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MOUNJARO, Cologuard Collection Kit, Wegovy, FARXIGA, THINPREP 2000 PROCESSOR, ELIQUIS, ZEPBOUND, GEMTESA.
Industry payments across MO — which companies pay providers there.
